{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:21:47Z","timestamp":1792300907202,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clindermatol.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:02:38Z","timestamp":1593180158000},"page":"693-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Drug reactions affecting hair and nails"],"prefix":"10.1016","volume":"38","author":[{"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Badawy","family":"Abdel-Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.06.009_bb0005","first-page":"509","article-title":"The diagnosis and treatment of nail disorders","volume":"113","author":"Wollina","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0010","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.celrep.2016.02.078","article-title":"Signaling networks among stem cell precursors, transit-amplifying progenitors, and their niche in developing hair follicles","volume":"14","author":"Rezza","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.fsc.2018.06.003","article-title":"Hair biology: growth and pigmentation","volume":"26","author":"Park","year":"2018","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0020","first-page":"41","article-title":"Dermal adipose tissue in hair follicle cycling: possible applications in alopecia?","volume":"265","author":"Wollina","year":"2017","journal-title":"Georgian Med News"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2133.2005.06608.x","article-title":"\u2018Atrophic telogen effluvium\u2019 from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans","volume":"153","author":"Bleiker","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2165\/00002018-199410040-00005","article-title":"Drug-induced hair loss and hair growth. Incidence, management and avoidance","volume":"10","author":"Tosti","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40801-015-0056-z","article-title":"Traditional anticoagulants and hair loss: a role for direct oral anticoagulants? A review of the literature","volume":"3","author":"Watras","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/0970-2113.76304","article-title":"Isoniazid-induced alopecia","volume":"28","author":"Gupta","year":"2011","journal-title":"Lung India"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0045","series-title":"IVDL\u2019s Textbook on Cutaneous Adverse Drug Reactions: A Comprehensive Guide","first-page":"187","article-title":"Cutaneous adverse drug reactions and the hair","author":"Kaliyadan","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2133.1990.tb06262.x","article-title":"A study of etretinate alopecia","volume":"122","author":"Berth-Jones","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0060","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia","volume":"155","author":"Freites-Martinez","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/15569527.2014.948684","article-title":"Acitretin-induced alopecia areata: a case report","volume":"34","author":"Ozlu","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jdcr.2018.10.010","article-title":"Drug-induced alopecia after dupilumab therapy","volume":"5","author":"Flanagan","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/DAD.0b013e3181ef7403","article-title":"Psoriatic alopecia\/alopecia areata-like reactions secondary to anti-tumor necrosis factor-\u03b1 therapy: a novel cause of noncicatricial alopecia","volume":"33","author":"Doyle","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1258\/0956462001916146","article-title":"Indinavir use: associated reversible hair loss and mood disturbance","volume":"11","author":"Harry","year":"2000","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0974-7753.203174","article-title":"Extreme phenotype of epidermal growth factor receptor inhibitor-induced destructive folliculitis","volume":"8","author":"Anzengruber","year":"2016","journal-title":"Int J Trichol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0095","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1111\/jdv.15571","article-title":"Hair regrowth and dissemination of molluscum contagiosum: two unexpected effects with dupilumab","volume":"33","author":"Sevray","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0100","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2018.2976","article-title":"Hair regrowth in a patient with long-standing alopecia totalis and atopic dermatitis treated with dupilumab","volume":"154","author":"Penzi","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biomaterials.2018.03.019","article-title":"Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth","volume":"167","author":"Fakhraei Lahiji","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1468-3083.1998.tb00981.x","article-title":"Partial regrowth of scalp hair in a patient treated with extracorporeal photochemotherapy and interferon alpha 2a","volume":"11","author":"Wollina","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ndt\/gfh766","article-title":"Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis","volume":"20","author":"Mahmoud","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0120","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","article-title":"Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience","volume":"20","author":"El-Husseini","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/pde.12329","article-title":"Piggyback-acquired hypertrichosis","volume":"31","author":"Farsani","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/abd1806-4841.20164010","article-title":"Infantile generalized hypertrichosis caused by topical minoxidil","volume":"91","author":"Rampon","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/106002809002400404","article-title":"Drug-induced hypertrichosis: case report and review of the literature","volume":"24","author":"Miwa","year":"1990","journal-title":"DICP"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0145","unstructured":"Chachia L, Tkeshelashvili B, Gagua T, Tananashvili D, Gagua D. The prevalence of hirsutism and ethnical peculiarities of hair distribution in Georgian adolescent population in Tbilisi. Georgian Med News. 2018;280-281:64-68."},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0019-5154.60342","article-title":"Hirsutism: evaluation and treatment","volume":"55","author":"Sachdeva","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0155","first-page":"117","article-title":"Side-effects of topical androgenic and anabolic substances and steroids: a short review","volume":"16","author":"Wollina","year":"2007","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0160","doi-asserted-by":"crossref","first-page":"e1226","DOI":"10.1097\/MJT.0000000000000189","article-title":"Trichomegaly induced by cetuximab: case series and review the literature","volume":"23","author":"Koksal","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/15569527.2011.636118","article-title":"Trichomegaly and other external eye side effects associated with epidermal growth factor","volume":"31","author":"Fraunfelder","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clindermatol.2014.10.013","article-title":"Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis","volume":"33","author":"Vij","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0175","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2133.2010.09685.x","article-title":"Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost","volume":"162","author":"Tauchi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/exd.13347","article-title":"The biology and genetics of curly hair","volume":"26","author":"Westgate","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/ijt.ijt_10_18","article-title":"Valproate: it\u2019s effects on hair","volume":"10","author":"Kakunje","year":"2018","journal-title":"Int J Trichol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s40800-018-0092-1","article-title":"Curling of hair in two female patients taking alitretinoin","volume":"5","author":"Alting","year":"2018","journal-title":"Drug Saf Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1440-0960.2009.00542.x","article-title":"Repigmentation and curling of hair after acitretin therapy","volume":"50","author":"Seckin","year":"2009","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0200","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/pgmj.64.757.907","article-title":"Hair changes following cytotoxic drug induced alopecia","volume":"64","author":"Fairlamb","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0205","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archderm.135.10.1223","article-title":"Acquired progressive kinking of the hair: clinical features, pathological study, and follow-up of 7 patients","volume":"135","author":"Tosti","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0210","first-page":"937","article-title":"Acquired kinking of the hair caused by acitretin","volume":"6","author":"Clarke","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0215","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/ijt.ijt_4_19","article-title":"Drug-associated plica polonica: an unususal presentation","volume":"11","author":"Kumar","year":"2019","journal-title":"Int J Trichol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0220","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2133.2002.48215.x","article-title":"Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection","volume":"147","author":"Bessis","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1684\/ejd.2016.2844","article-title":"Drug-induced hair colour changes","volume":"26","author":"Ricci","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0190-9622(88)80265-2","article-title":"Yellow hair discoloration due to anthralin","volume":"19","author":"Rogers","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0235","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/ijd.13594","article-title":"Propofol-induced irreversible hair depigmentation: a case report","volume":"56","author":"Ricci","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2710.1992.tb01307.x","article-title":"Drug-induced hair color changes","volume":"17","author":"Bublin","year":"1992","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000075046","article-title":"A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma","volume":"208","author":"Guillot","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0250","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jaad.2013.05.022","article-title":"Poliosis circumscripta: overview and underlying causes","volume":"69","author":"Sleiman","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0255","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/art.23652","article-title":"Clinical image: blonde by prescription","volume":"58","author":"Meller","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0260","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/1346-8138.13514","article-title":"Manifest hair repigmentation associated with etretinate therapy","volume":"44","author":"Nagase","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1574887113666181120111104","article-title":"Hair loss prevention by a scalp cooling device in early breast cancer patients: the Poliambulanza preliminary experience","volume":"14","author":"Prochilo","year":"2019","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2018.04.012","article-title":"Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline\/taxane-based chemotherapy","volume":"40","author":"Vasconcelos","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0275","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy-induced alopecia in patients with breast cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/14764172.2017.1376099","article-title":"Laser-assisted hair removal for facial hirsutism in women: a review of evidence","volume":"20","author":"Lee","year":"2018","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0285","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0190-9622(88)70078-X","article-title":"Adverse reactions to isotretinoin: a report from the Adverse Drug Reaction Reporting System","volume":"18","author":"Bigby","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2230.1986.tb00439.x","article-title":"Etretinate and the nails (study of 130 cases): possible mechanisms of some side-effects","volume":"11","author":"Baran","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0295","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/idoj.IDOJ_133_18","article-title":"Systemic drug-induced chronic paronychia and periungual pyogenic granuloma","volume":"9","author":"Wollina","year":"2018","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0300","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12885-015-1685-z","article-title":"Multicenter phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS\/BRAF metastatic colorectal cancer: the FLEET study","volume":"15","author":"Soda","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0305","first-page":"509","article-title":"A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group","volume":"18","author":"Lacouture","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000490177","article-title":"Relationship between paronychia and drug concentrations of epidermal growth factor receptor tyrosine kinase inhibitors","volume":"95","author":"Masago","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ajco.12687","article-title":"Management of epidermal growth factor receptor tyrosine kinase inhibitor-related cutaneous and gastrointestinal toxicities","volume":"14","author":"Aw","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0320","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s10637-010-9567-3","article-title":"Dermatologic side effects associated with the MEK 1\/2 inhibitor selumetinib (AZD6244, ARRY-142886)","volume":"29","author":"Balagula","year":"2011","journal-title":"Investig New Drugs"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0325","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11912-013-0308-6","article-title":"Dermatological adverse events from BRAF inhibitors: a growing problem","volume":"15","author":"Belum","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0330","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.annder.2013.02.023","article-title":"Effets ind\u00e9sirables cutan\u00e9s et retentissement sur la qualit\u00e9 de vie des inhibiteurs de mTOR au cours du traitement du cancer du rein","volume":"140","author":"Voilliot-Trotot","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3315\/jdcr.2010.1050","article-title":"Multiple eruptive periungual pyogenic granulomas during anti-CD20 monoclonal antibody therapy for rheumatoid arthritis","volume":"4","author":"Wollina","year":"2010","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0340","first-page":"262","article-title":"Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving paclitaxel and review of drug-induced pyogenic granulomas adjacent to and beneath the nail","volume":"11","author":"Paul","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0345","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1420912","article-title":"PATEO syndrome: periarticular thenar erythema with onycholysis","volume":"57","author":"Rzepecki","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000486021","article-title":"Asymmetric acral spared phenomenon related to systemic anticancer therapies","volume":"4","author":"Baran","year":"2018","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0355","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0190-9622(87)70291-6","article-title":"Drug-induced photo-onycholysis: three subtypes identified in a study of 15 cases","volume":"17","author":"Baran","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0360","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jdv.15151","article-title":"Photoonycholysis: new findings","volume":"33","author":"Baran","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0365","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000458761","article-title":"Phototoxicity of doxycycline: a systematic review on clinical manifestations, frequency, cofactors, and prevention","volume":"30","author":"Goetze","year":"2017","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0370","first-page":"662","article-title":"Doxycycline-induced photo-onycholysis","volume":"2","author":"Carroll","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0375","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/15569527.2010.498397","article-title":"Docetaxel-induced acral erythema and nail changes distributed to photoexposed areas","volume":"29","author":"Ferreira","year":"2010","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0380","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0151-9638(06)70957-7","article-title":"Onychopathie associ\u00e9e au sirolimus chez les transplant\u00e9s r\u00e9naux","volume":"133","author":"Mah\u00e9","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0385","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1610-0387.2005.05063.x","article-title":"Black discoloration of nails in polycythaemia vera","volume":"9","author":"Konrad","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0390","doi-asserted-by":"crossref","unstructured":"Nguyen AL, K\u00f6rver JE, Theunissen CCW. Longitudinal melanonychia on multiple nails induced by hydroxyurea. BMJ Case Rep. 2017;2017:bcr2016218644.","DOI":"10.1136\/bcr-2016-218644"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0395","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-017-0594-4","article-title":"Yellow nail syndrome: a review","volume":"12","author":"Vignes","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0400","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000338893","article-title":"Onychopathy induced by temsirolimus, a mammalian target of rapamycin inhibitor","volume":"224","author":"Peuvrel","year":"2012","journal-title":"Dermatology"},{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2020.06.009_bb0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40257-018-0384-3","article-title":"Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails","volume":"19","author":"Lacouture","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0410","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S1470-2045(14)71133-7","article-title":"Nail toxicities induced by systemic anticancer treatments","volume":"16","author":"Robert","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0415","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09168451.2017.1386084","article-title":"Branched-chain amino acids regulate type I tropocollagen and type III tropocollagen syntheses via modulation of mTOR in the skin","volume":"82","author":"Yamane","year":"2018","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0420","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","article-title":"Evaluation of prevention interventions for taxane-induced dermatologic adverse events: a systematic review","volume":"154","author":"Marks","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0425","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/09546634.2017.1395799","article-title":"Biotin for the treatment of nail disease: what is the evidence?","volume":"29","author":"Lipner","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0430","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0974-2077.129968","article-title":"Utility of gel nails in improving the appearance of cosmetically disfigured nails: experience with 25 cases","volume":"7","author":"Nanda","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0435","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1468-3083.2001.00177-6.x","article-title":"Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid","volume":"15","author":"Wollina","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.009_bb0440","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3889\/oamjms.2017.111","article-title":"Pyogenic granuloma \u2013 a common benign vascular tumor with variable clinical presentation: new findings and treatment options","volume":"5","author":"Wollina","year":"2017","journal-title":"Open Access Maced J Med Sci"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:54Z","timestamp":1760033874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0738081X20301425"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug reactions affecting hair and nails","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}